These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31674740)

  • 41. [Systemic treatment of moderate/severe hidradenitis suppurativa].
    Pinter A; Mrowietz U; Volz T
    Hautarzt; 2021 Aug; 72(8):686-691. PubMed ID: 34189590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hidradenitis suppurativa: a review with a focus on treatment data.
    Barlev D; Eisen DB; Alikhan A
    Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches.
    Garcovich S; Fania L; Caposiena D; Giovanardi G; Chiricozzi A; De Simone C; Tartaglia C; Ciccone D; Bianchi L; Abeni D; Peris K
    J Cutan Med Surg; 2022; 26(2):127-134. PubMed ID: 34615396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
    Bettoli V; Zauli S; Virgili A
    G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
    [No Abstract]   [Full Text] [Related]  

  • 49. Hidradenitis suppurativa managed with adalimumab.
    Yamauchi PS; Mau N
    J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
    Megna M; Bettoli V; Chimenti S; Chiricozzi A; Naldi L; Virgili A; Girolomoni G; Monfrecola G
    G Ital Dermatol Venereol; 2015 Dec; 150(6):731-9. PubMed ID: 26513043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hidradenitis suppurativa: Current and emerging treatments.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hidradenitis suppurativa in children and young adults: a retrospective cross-sectional observational study in the United Kingdom.
    McGrath C; Steyn M; Rashidghamat E
    Int J Dermatol; 2024 Jul; 63(7):904-906. PubMed ID: 38273707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
    Cline A; Pichardo RO
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
    Martina E; Campanati A; Giuliodori K; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
    Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
    Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local wound care and topical management of hidradenitis suppurativa.
    Alavi A; Kirsner RS
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
    Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
    Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.